283 related articles for article (PubMed ID: 19174153)
1. Linking anemia to inflammation and cancer: the crucial role of TNFalpha.
Buck I; Morceau F; Grigorakaki C; Dicato M; Diederich M
Biochem Pharmacol; 2009 May; 77(10):1572-9. PubMed ID: 19174153
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
[TBL] [Abstract][Full Text] [Related]
3. Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis.
Morceau F; Dicato M; Diederich M
Mediators Inflamm; 2009; 2009():405016. PubMed ID: 20204172
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor α-mediated inhibition of erythropoiesis involves GATA-1/GATA-2 balance impairment and PU.1 over-expression.
Grigorakaki C; Morceau F; Chateauvieux S; Dicato M; Diederich M
Biochem Pharmacol; 2011 Jul; 82(2):156-66. PubMed ID: 21501595
[TBL] [Abstract][Full Text] [Related]
5. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
Wang W; Zhang MH; Yu Y; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
[TBL] [Abstract][Full Text] [Related]
6. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
[TBL] [Abstract][Full Text] [Related]
7. New insights into the regulation of erythroid cells.
Ingley E; Tilbrook PA; Klinken SP
IUBMB Life; 2004 Apr; 56(4):177-84. PubMed ID: 15230344
[TBL] [Abstract][Full Text] [Related]
8. Anemia of chronic disease: a review of pathogenesis.
DeRienzo DP; Saleem A
Tex Med; 1990 Oct; 86(10):80-3. PubMed ID: 2247849
[TBL] [Abstract][Full Text] [Related]
9. Erythroid-stimulating agents in cancer therapy: potential dangers and biologic mechanisms.
Hadland BK; Longmore GD
J Clin Oncol; 2009 Sep; 27(25):4217-26. PubMed ID: 19636005
[TBL] [Abstract][Full Text] [Related]
10. Cytokines and anaemia in human immunodeficiency virus infection.
Means RT
Cytokines Cell Mol Ther; 1997 Sep; 3(3):179-86. PubMed ID: 9426976
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin, erythropoiesis and beyond.
Chateauvieux S; Grigorakaki C; Morceau F; Dicato M; Diederich M
Biochem Pharmacol; 2011 Nov; 82(10):1291-303. PubMed ID: 21782802
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of renal anemia.
Nangaku M; Eckardt KU
Semin Nephrol; 2006 Jul; 26(4):261-8. PubMed ID: 16949463
[TBL] [Abstract][Full Text] [Related]
13. Anemia management in oncology and hematology.
Spivak JL; Gascón P; Ludwig H
Oncologist; 2009; 14 Suppl 1():43-56. PubMed ID: 19762516
[TBL] [Abstract][Full Text] [Related]
14. Cancer-related anemia: its causes and characteristics.
Spivak JL
Semin Oncol; 1994 Apr; 21(2 Suppl 3):3-8. PubMed ID: 8202724
[TBL] [Abstract][Full Text] [Related]
15. Possible role of cytokine-induced tryptophan degradation in anaemia of inflammation.
Weiss G; Schroecksnadel K; Mattle V; Winkler C; Konwalinka G; Fuchs D
Eur J Haematol; 2004 Feb; 72(2):130-4. PubMed ID: 14962250
[TBL] [Abstract][Full Text] [Related]
16. Oxygen breathing may be a cheaper and safer alternative to exogenous erythropoietin (EPO).
Burk R
Med Hypotheses; 2007; 69(6):1200-4. PubMed ID: 17493766
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha inhibits aclacinomycin A-induced erythroid differentiation of K562 cells via GATA-1.
Morceau F; Schnekenburger M; Blasius R; Buck I; Dicato M; Diederich M
Cancer Lett; 2006 Aug; 240(2):203-12. PubMed ID: 16274927
[TBL] [Abstract][Full Text] [Related]
18. Hyporesponsiveness to erythropoietic therapy due to chronic inflammation.
Macdougall IC; Cooper AC
Eur J Clin Invest; 2005 Dec; 35 Suppl 3():32-5. PubMed ID: 16281956
[TBL] [Abstract][Full Text] [Related]
19. The anemia of inflammation/malignancy: mechanisms and management.
Adamson JW
Hematology Am Soc Hematol Educ Program; 2008; ():159-65. PubMed ID: 19074075
[TBL] [Abstract][Full Text] [Related]
20. Low oxygen concentration as a general physiologic regulator of erythropoiesis beyond the EPO-related downstream tuning and a tool for the optimization of red blood cell production ex vivo.
Vlaski M; Lafarge X; Chevaleyre J; Duchez P; Boiron JM; Ivanovic Z
Exp Hematol; 2009 May; 37(5):573-84. PubMed ID: 19375648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
